PL370074A1 - Piranony użyteczne jako inhibitory ATM - Google Patents

Piranony użyteczne jako inhibitory ATM

Info

Publication number
PL370074A1
PL370074A1 PL03370074A PL37007403A PL370074A1 PL 370074 A1 PL370074 A1 PL 370074A1 PL 03370074 A PL03370074 A PL 03370074A PL 37007403 A PL37007403 A PL 37007403A PL 370074 A1 PL370074 A1 PL 370074A1
Authority
PL
Poland
Prior art keywords
atm inhibitors
pyranones
useful
pyranones useful
sulfonamino
Prior art date
Application number
PL03370074A
Other languages
English (en)
Inventor
Graeme Cameron Murray Smith
Niall Morrison Barr Martin
Stephen Philip Jackson
Mark James O'connor
Alan Yin Kai Lau
Xiao-Ling Fan Cockcroft
Ian Timothy Williams Matthews
Keith Allan Menear
Laurent Jean Martin Rigoreau
Marc Geoffrey Hummersone
Roger John Griffin
Original Assignee
Kudos Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0204350.3A external-priority patent/GB0204350D0/en
Application filed by Kudos Pharmaceuticals Ltd filed Critical Kudos Pharmaceuticals Ltd
Publication of PL370074A1 publication Critical patent/PL370074A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • AIDS & HIV (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL03370074A 2002-02-25 2003-02-24 Piranony użyteczne jako inhibitory ATM PL370074A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0204350.3A GB0204350D0 (en) 2002-02-25 2002-02-25 ATM inhibitors
US39588402P 2002-07-15 2002-07-15

Publications (1)

Publication Number Publication Date
PL370074A1 true PL370074A1 (pl) 2005-05-16

Family

ID=27758841

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03370074A PL370074A1 (pl) 2002-02-25 2003-02-24 Piranony użyteczne jako inhibitory ATM

Country Status (19)

Country Link
EP (2) EP2174939A1 (pl)
JP (1) JP2005521689A (pl)
CN (1) CN100358891C (pl)
AT (1) ATE451365T1 (pl)
AU (1) AU2003209990B8 (pl)
BR (1) BR0307944A (pl)
CA (1) CA2473100A1 (pl)
CY (1) CY1109835T1 (pl)
DE (1) DE60330442D1 (pl)
DK (1) DK1485377T5 (pl)
ES (1) ES2336206T3 (pl)
GB (1) GB2401606B (pl)
MX (1) MXPA04007809A (pl)
NO (1) NO329806B1 (pl)
NZ (1) NZ534821A (pl)
PL (1) PL370074A1 (pl)
PT (1) PT1485377E (pl)
SI (1) SI1485377T1 (pl)
WO (1) WO2003070726A1 (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7151102B2 (en) 2000-10-30 2006-12-19 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0119863D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
GB0119865D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
DE60335359D1 (de) 2002-04-30 2011-01-27 Kudos Pharm Ltd Phthalazinonderivate
US7122189B2 (en) * 2002-08-13 2006-10-17 Enzon, Inc. Releasable polymeric conjugates based on aliphatic biodegradable linkers
US7413738B2 (en) 2002-08-13 2008-08-19 Enzon Pharmaceuticals, Inc. Releasable polymeric conjugates based on biodegradable linkers
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
US7449464B2 (en) 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
US20070099186A1 (en) * 2003-05-01 2007-05-03 D Adda Di Fagagna Fabrizio Methods and means for the treatment of disorders associated with cellular senescence
AU2004265149A1 (en) 2003-08-13 2005-02-24 Kudos Pharmaceuticals Limited Aminopyrones and their use as ATM inhibitors
PL2305221T3 (pl) 2003-12-01 2015-11-30 Kudos Pharm Ltd Inhibitory naprawy uszkodzeń DNA w leczeniu raka
WO2005118543A1 (ja) * 2004-06-03 2005-12-15 Ono Pharmaceutical Co., Ltd. キナーゼ阻害薬およびその用途
GB0419072D0 (en) 2004-08-26 2004-09-29 Kudos Pharm Ltd Phthalazinone derivatives
BRPI0515498A (pt) 2004-09-20 2008-07-29 Kudos Pharm Ltd inibidores de dna-pk
EP1848712A1 (en) * 2005-02-09 2007-10-31 Kudos Pharmaceuticals Ltd Atm inhibitors
AR053358A1 (es) 2005-04-15 2007-05-02 Cancer Rec Tech Ltd Inhibidores de adn - pk
US20070049588A1 (en) * 2005-08-31 2007-03-01 Kudos Pharmaceuticals Limited Atm inhibitor
GB0521373D0 (en) 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
MX2010002749A (es) 2007-09-14 2010-06-25 Astrazeneca Ab Derivados de ftalazinona.
CA2737400C (en) 2008-10-07 2016-11-22 Astrazeneca Uk Limited Pharmaceutical formulation 514
EP2486923B1 (en) * 2011-02-11 2015-09-09 Dr. Felix Jäger und Dr. Stefan Drinkuth Laborgemeinschaft OHG Histone deacetylase (HDAC) inhibiting compounds and method of making same
WO2013003112A1 (en) 2011-06-27 2013-01-03 The Jackson Laboratory Methods and compositions for treatment of cancer and autoimmune disease
JP6074043B2 (ja) * 2013-08-29 2017-02-01 富士フイルム株式会社 新規なモルホリン誘導体またはその塩
US20230256110A1 (en) 2020-06-24 2023-08-17 Astrazeneca Uk Limited Combination of antibody-drug conjugate and atm inhibitor
CN112094210A (zh) * 2020-09-24 2020-12-18 江苏扬农化工股份有限公司 一种取代的亚磺酸盐的制备方法
JPWO2024214685A1 (pl) 2023-04-10 2024-10-17

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282155A (en) * 1980-02-04 1981-08-04 Merck & Co., Inc. Antihypercholesterolemic compounds
DE68914495T2 (de) * 1988-03-02 1994-10-27 Merck & Co Inc Antihypercholesterolemisches Mittel.
ATE128128T1 (de) * 1990-06-29 1995-10-15 Upjohn Co Antiatherosclerotische und antithrombotische 2- amino-6-phenyl-4h-pyran-4-one.
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
WO1997043434A1 (en) * 1996-05-14 1997-11-20 Snow Brand Milk Products Co., Ltd. Novel physiologically active substance and process for producing the same
FR2765579A1 (fr) * 1997-07-01 1999-01-08 Lipha Nouveaux derives de 4-hydroxy-2h-1-(thio)pyran-2-ones leurs preparations et leurs utilisations comme rodonticides
CN1205198C (zh) * 1997-09-26 2005-06-08 东丽株式会社 环酮衍生物及其医药用途
HUP0101381A3 (en) * 1998-03-12 2002-06-28 Microbial Chem Res Found Benzofurylpyrone derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JP2005521689A (ja) 2005-07-21
EP1485377B1 (en) 2009-12-09
DK1485377T3 (da) 2010-04-19
CA2473100A1 (en) 2003-08-28
CN1639154A (zh) 2005-07-13
CN100358891C (zh) 2008-01-02
EP1485377A1 (en) 2004-12-15
ES2336206T3 (es) 2010-04-09
SI1485377T1 (sl) 2010-04-30
NO329806B1 (no) 2010-12-20
ATE451365T1 (de) 2009-12-15
EP1485377B8 (en) 2010-02-24
GB0419534D0 (en) 2004-10-06
MXPA04007809A (es) 2004-10-15
EP2174939A1 (en) 2010-04-14
EP1485377B9 (en) 2010-10-06
AU2003209990A1 (en) 2003-09-09
GB2401606B (en) 2005-08-31
ES2336206T9 (es) 2011-03-24
AU2003209990B8 (en) 2008-10-30
WO2003070726A1 (en) 2003-08-28
CY1109835T1 (el) 2014-09-10
AU2003209990B2 (en) 2008-10-09
NO20044063L (no) 2004-09-24
HK1069827A1 (zh) 2005-06-03
DE60330442D1 (de) 2010-01-21
GB2401606A (en) 2004-11-17
NZ534821A (en) 2006-07-28
DK1485377T5 (da) 2010-12-06
BR0307944A (pt) 2005-02-01
PT1485377E (pt) 2010-03-12

Similar Documents

Publication Publication Date Title
GB2401606B (en) Pyranones useful as ATM inhibitors
GB2420781B (en) Aminopyrones and their use as ATM inhibitors
GB0226593D0 (en) Compounds
UA88329C2 (en) Dna-pk inhibitors
TWI266761B (en) Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
MXPA02011974A (es) Derivados de quinazolina sustituidos y su uso como inhibidores.
MEP61208A (bs) Nova jedinjenja koja imaju inhibitorno dejstvo na transporter glukoze zavistan od natrijuma
CY1111310T1 (el) Ενωσεις για την αγωγη μεταβολικων διαταραχων
HUP0301607A2 (hu) Szelektív neurokinin antagonista hatású nitrogéntartalmú heterociklusos vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
GEP20125523B (en) Metabolites of (thio) carbamoyl-cyclohexane derivatives
FI931763A0 (fi) 4,1-bensoxazepinderivat och deras anvaendning
WO2005037785A3 (fr) Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide, et n-[azepan-2-yl) phenylmethyl]benzamide, leur preparation et leur application en therapeutique
MX9700675A (es) Compuestos utiles como agentes antiproliferativos e inhibidores de la glicinamida ribonucleotido formil transferasa.
TW200638938A (en) ATM inhibitors
CO5580821A2 (es) 4-cetolactamas y -lactonas 3-fenil-3-substituidas, espirociclicas
WO2001098248A3 (en) Hiv integrase inhibitors
ZA200106514B (en) Heterocyclic compounds intermediates thereof and elastase inhibitors.
HRP20020440B1 (en) 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
FI935798A0 (fi) Alkylsubstituerade heterocykliska foereningar
GB0116312D0 (en) "Compositions containing N-acyl homoserine lactones"
NZ506908A (en) Cephalosporines having cyclic aminoguanidine substituents as antibiotics
ES2166710A1 (es) Nuevos compuestos heterociclicos con actividad antiinflamatoria.
ATE500243T1 (de) Carbonsäureamidverbindung und deren verwendung
MY134476A (en) Aromatic compounds, their production processes and their compositions for the control of insect pests
IL178548A0 (en) Derivatives of 14,15-dihydro 20,21-dinoreburnamenin-14-ol, and applications thereof

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)